Integrated Nonclinical Development Solutions (United States)

Recent papers from Integrated Nonclinical Development Solutions (United States)

1. Moss-derived recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathyFrontiers in Immunology · 2026
2. Technical and Vocational Education as a Driver of Post-Conflict Reconstruction: Quality, Employability and Social Cohesion in Rwanda's Integrated Polytechnic Regional Colleges (IPRCs)2026
3. Abstract PS4-09-01: Listening to the Community: Barriers and Beliefs About Clinical Trials Among Black Women with Breast CancerClinical Cancer Research · 2026
4. Exploring Vaccine Hesitancy Among Parents in a Tribal Community: A Cross-Sectional Study in Ormanjhi, JharkhandCureus · 2025
5. Noninvasive and Minimally Invasive Multimodal Sensing for Continuous Cerebral Blood Flow Monitoring After TBIIEEE Sensors Journal · 2025
6. Renal macro- and microcirculatory perturbations in acute kidney injury and chronic kidney disease associated with heart failure and cardiac surgeryAJP Renal Physiology · 2025
7. Modulation of Affective and Sensory Qualities of Acute Nociceptive Pain by Curcuma longa and Boswellia serrata Extract Formulation: A Randomized, Double-Blind, Placebo-Controlled Design in Subjects With Exercise-Induced Acute Musculoskeletal PainCureus · 2025
8. Prediction of long-term polysorbate degradation according to short-term degradation kineticsmAbs · 2023
9. Improving corrected QT; Why individual correction is not enoughJournal of Pharmacological and Toxicological Methods · 2021
10. Absence of effect of steady state bempedoic acid on cardiac repolarization: Results of a thorough QT/QTc study in healthy volunteersClinical and Translational Science · 2021
11. Thoracic Lymph Duct Catheterization with a Venous Shunt in the Nonhuman PrimateJournal of Investigative Surgery · 2021
12. A general evidence-based sequence variant control limit for recombinant therapeutic protein developmentmAbs · 2020
13. Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain DisordersJournal of Medicinal Chemistry · 2019
14. Design and Conduct Considerations for First‐in‐Human TrialsClinical and Translational Science · 2018
15. Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau NeuropathologyJournal of Visualized Experiments · 2017
16. Data Standardization, Pharmaceutical Drug Development, and the 3RsILAR Journal · 2016
17. Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey PharmacokineticsJournal of Biological Chemistry · 2015
18. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton ratsHuman Vaccines & Immunotherapeutics · 2015
19. Recommendations for Safety Pharmacology Evaluations of Oligonucleotide-Based TherapeuticsNucleic Acid Therapeutics · 2014
20. Clinical Expert Panel on Monitoring Potential Lung Toxicity of Inhaled Oligonucleotides: Consensus Points and RecommendationsNucleic Acid Therapeutics · 2012